CLL Therapy Approaches in Russia - CLL registry

Study identifier:D8220R00038

ClinicalTrials.gov identifier:NCT05140369

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

Observational Retrospective-Prospective Study on CLL Therapy Approaches in Russia.

Medical condition

Chronic Lymphocytic Leukemia

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

6000

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 29 Oct 2021
Estimated Primary Completion Date: 30 Mar 2028
Estimated Study Completion Date: 30 Mar 2028

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria